Axsome Therapeutics, Inc.
Clinical trials sponsored by Axsome Therapeutics, Inc., explained in plain language.
-
New fibromyalgia drug trial tests Long-Term relief
Disease control Recruiting nowThis study is testing whether the medication AXS-14 can help manage fibromyalgia symptoms over time. The trial involves 620 adults with fibromyalgia who will first receive the medication for 12 weeks. Those who respond well will then be randomly assigned to either continue the me…
Phase: PHASE3 • Sponsor: Axsome Therapeutics, Inc. • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
New hope for depressed patients who struggle to stay awake
Disease control Recruiting nowThis study is testing whether a drug called solriamfetol can help control symptoms in adults with major depression who also experience severe daytime sleepiness. First, all 508 participants will receive the active drug. Those who respond well will then be randomly assigned to eit…
Phase: PHASE3 • Sponsor: Axsome Therapeutics, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New hope for controlling binge eating episodes
Disease control Recruiting nowThis study is testing whether a medication called solriamfetol can help reduce binge eating episodes in adults with binge eating disorder. About 450 participants will take either the medication at one of two doses or a placebo pill daily for 12 weeks. The main goal is to see if t…
Phase: PHASE3 • Sponsor: Axsome Therapeutics, Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New drug trial aims to help night shift workers stay awake
Symptom relief Recruiting nowThis study is testing whether a medication called solriamfetol can safely reduce excessive sleepiness in adults with shift work disorder. About 520 participants who work night shifts will take either the drug or a placebo for 12 weeks. Researchers will measure how well it helps p…
Phase: PHASE3 • Sponsor: Axsome Therapeutics, Inc. • Aim: Symptom relief
Last updated Apr 03, 2026 14:43 UTC